Home / Health / Metro Health’s Appointment Schedule for COVID-19 II

Metro Health’s Appointment Schedule for COVID-19 II



San antonio – The San Antonio Metropolitan Health District has begun scheduling appointments for a second COVID-19 vaccination.

Patients who received their first vaccine by noon Wednesday at Alamodome were eligible for the disclosure, the news said.

Previously, those who had been vaccinated were ordered to register online one week before their second dose was due. But that’s not the case any longer, officials said.

Patients will receive a call from Metro Health to schedule a second dose. If someone missed the call and would like to schedule a time, they can call 31

1 and select option 8 or send an email to COVID19@sanantonio.gov

Currently, only at the forefront of medical personnel and long-term care residents. (Referred to as stage 1A), including those 65 years of age or older or with chronic medical conditions that increase the risk of serious illness from COVID-19 (called stage 1B) are currently eligible for the COVID-19 vaccine.

Phase 1B recipients are:

  • People over 65 years of age
  • People 16 years and older with one or more chronic medical conditions that put them at increased risk for serious viral illness that causes COVID-19, such as but not limited to:
  • Cancer
  • Chronic kidney disease
  • COPD (Chronic Obstructive Pulmonary Disease)
  • Heart conditions such as heart failure, coronary heart disease, or cardiomyopathies
  • Solid organ transplant
  • Severe obesity and obesity (body mass index 30 kg / m2 or higher).
  • Pregnancy
  • Sickle cell disease
  • Type 2 diabetes

As Bexar County continues to receive more vaccines, more appointments will be opened. Ask residents to check daily to see if an appointment is available on the city website, or call 311 and choose option 8.

The Alamodome Vaccine Clinic opening hours are 9 AM – 6:30 PM Monday through Saturday.

For more information, click here and for FAQs, click here.

Related stories:

Copyright 2021 by KSAT – All rights reserved.


Source link